| 000 | 01661 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250516073319.0 | ||
| 264 | 0 | _c20120509 | |
| 008 | 201205s 0 0 eng d | ||
| 022 | _a1537-6591 | ||
| 024 | 7 |
_a10.1093/cid/cir711 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWiersinga, Willem Joost | |
| 245 | 0 | 0 |
_aTherapy-resistant opsoclonus-myoclonus syndrome secondary to HIV-1 infection. _h[electronic resource] |
| 260 |
_bClinical infectious diseases : an official publication of the Infectious Diseases Society of America _cFeb 2012 |
||
| 300 |
_a447-8 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAmines _xtherapeutic use |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCyclohexanecarboxylic Acids _xtherapeutic use |
| 650 | 0 | 4 |
_aExcitatory Amino Acid Antagonists _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGabapentin |
| 650 | 0 | 4 |
_aHIV Infections _xcomplications |
| 650 | 0 | 4 | _aHIV-1 |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulins, Intravenous _xtherapeutic use |
| 650 | 0 | 4 |
_aOpsoclonus-Myoclonus Syndrome _xetiology |
| 650 | 0 | 4 |
_aPrednisolone _xtherapeutic use |
| 650 | 0 | 4 |
_aRNA, Viral _xblood |
| 650 | 0 | 4 | _aTreatment Failure |
| 650 | 0 | 4 |
_agamma-Aminobutyric Acid _xtherapeutic use |
| 700 | 1 | _aPrins, Jan M | |
| 700 | 1 | _avan de Beek, Diederik | |
| 773 | 0 |
_tClinical infectious diseases : an official publication of the Infectious Diseases Society of America _gvol. 54 _gno. 3 _gp. 447-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/cid/cir711 _zAvailable from publisher's website |
| 999 |
_c21463093 _d21463093 |
||